FIVE PRIME THERAPEUTICS INC - COM (FPRX)

CUSIP: 33830X104

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / COM
Total 13F shares
26,635,502
Share change
-681,061
Total reported value
$125,164,517
Put/Call ratio
69%
Price per share
$4.70
Number of holders
88
Value change
-$4,465,416
Number of buys
28
Number of sells
45

Quarterly Holders Quick Answers

What is CUSIP 33830X104?
CUSIP 33830X104 identifies FPRX - FIVE PRIME THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FIVE PRIME THERAPEUTICS INC - COM (FPRX) as of Q3 2020

As of 30 Sep 2020, FIVE PRIME THERAPEUTICS INC - COM (FPRX) was held by 88 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 26,635,502 shares. The largest 10 holders included BVF INC/IL, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, ACADIAN ASSET MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, and Assenagon Asset Management S.A.. This page lists 88 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.